165 related articles for article (PubMed ID: 29451308)
21. Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response.
Piccirillo N; Putzulu R; Massini G; Di Giovanni A; Giammarco S; Metafuni E; Sica S; Zini G; Chiusolo P
J Clin Apher; 2021 Feb; 36(1):118-126. PubMed ID: 33058243
[TBL] [Abstract][Full Text] [Related]
22. Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders.
Fox FE; Niu Z; Tobia A; Rook AH
J Invest Dermatol; 1998 Aug; 111(2):327-32. PubMed ID: 9699738
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis induction by extracorporeal photopheresis is enhanced by increasing the 8-methoxypsoralen concentration and by replacing plasma with saline.
Hähnel V; Brosig AM; Ehrenschwender M; Burkhardt R; Offner R; Ahrens N
Transfusion; 2021 Oct; 61(10):2991-2999. PubMed ID: 34427336
[TBL] [Abstract][Full Text] [Related]
24. Psoralen and UVA light: an in vitro investigation of multiple immunological mechanisms underlying the immunosuppression induction in allograft rejection.
Legitimo A; Consolini R; Di Stefano R; Bencivelli W; Mosca F
Blood Cells Mol Dis; 2002; 29(1):24-34. PubMed ID: 12482400
[TBL] [Abstract][Full Text] [Related]
25. Extracorporeal photopheresis as a therapy for autoimmune diseases.
Kuzmina Z; Stroncek D; Pavletic SZ
J Clin Apher; 2015 Aug; 30(4):224-37. PubMed ID: 25546289
[TBL] [Abstract][Full Text] [Related]
26. The down-regulation of IL1alpha and IL6, in monocytes exposed to extracorporeal photopheresis (ECP)-treated lymphocytes, is not dependent on lymphocyte phosphatidylserine externalization.
Bladon J; Taylor PC
Transpl Int; 2006 Apr; 19(4):319-24. PubMed ID: 16573548
[TBL] [Abstract][Full Text] [Related]
27. Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance.
Kusztal M; Kłak R; Krajewska M; Boratyńska M; Patrzałek D; Klinger M
Transplant Proc; 2011 Oct; 43(8):2941-2. PubMed ID: 21996195
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of action of extracorporeal photochemotherapy.
Heshmati F
Transfus Apher Sci; 2003 Aug; 29(1):61-70. PubMed ID: 12877896
[TBL] [Abstract][Full Text] [Related]
29. Photopheresis. Therapeutic potential in preventing restenosis after percutaneous transluminal coronary angioplasty.
Bisaccia E; Palangio M; Gonzalez J; Klainer AS; Banas JS
Am J Cardiovasc Drugs; 2003; 3(1):43-51. PubMed ID: 14727945
[TBL] [Abstract][Full Text] [Related]
30. Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?
Worel N; Lehner E; Führer H; Kalhs P; Rabitsch W; Mitterbauer M; Hopfinger G; Greinix HT
Transfusion; 2018 Apr; 58(4):1045-1053. PubMed ID: 29446444
[TBL] [Abstract][Full Text] [Related]
31. Validation of a new automated irradiation system for off-line ECP.
Del Fante C; Klersy C; Barone E; De Vitis S; Troletti D; Mortellaro C; Musella V; Perotti C
Transfus Apher Sci; 2023 Jun; 62(3):103724. PubMed ID: 37202323
[TBL] [Abstract][Full Text] [Related]
32. Mononuclear cell collection for extracorporeal photochemotherapy: a study comparing an automatic and a semiautomatic apheresis device.
Del Fante C; Scudeller L; Viarengo G; Cervio M; Perotti C
Transfusion; 2013 Sep; 53(9):2027-33. PubMed ID: 23305183
[TBL] [Abstract][Full Text] [Related]
33. [Documented effect of extra corporeal photopheresis on T-cell mediated diseases].
Kofoed K; Schiødt I; Gniadecki R
Ugeskr Laeger; 2011 Jun; 173(26):1869-74. PubMed ID: 21712008
[TBL] [Abstract][Full Text] [Related]
34. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
Atta M; Papanicolaou N; Tsirigotis P
Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605
[TBL] [Abstract][Full Text] [Related]
35. Photopheresis therapy for cutaneous T-cell lymphoma.
Duvic M; Hester JP; Lemak NA
J Am Acad Dermatol; 1996 Oct; 35(4):573-9. PubMed ID: 8859287
[TBL] [Abstract][Full Text] [Related]
36. Extracorporeal photopheresis promotes IL-1β production.
Yakut E; Jakobs C; Peric A; Michel G; Baal N; Bein G; Brüne B; Hornung V; Hackstein H
J Immunol; 2015 Mar; 194(6):2569-77. PubMed ID: 25681340
[TBL] [Abstract][Full Text] [Related]
37. Modification of extracorporeal photopheresis technology with porphyrin precursors. Comparison between 8-methoxypsoralen and hexaminolevulinate in killing human T-cell lymphoma cell lines in vitro.
Cunderlíková B; Vasovič V; Randeberg LL; Christensen E; Warloe T; Nesland JM; Peng Q
Biochim Biophys Acta; 2014 Sep; 1840(9):2702-8. PubMed ID: 24915603
[TBL] [Abstract][Full Text] [Related]
38. Validation of an apoptosis assay for extracorporeal photopheresis.
Hähnel V; Dormann F; Kronenberg K; Hutchinson JA; Burkhardt R; Ahrens N
Transfus Med; 2021 Apr; 31(2):113-120. PubMed ID: 33665869
[TBL] [Abstract][Full Text] [Related]
39. Red blood cell depletion from bone marrow and peripheral blood buffy coat: a comparison of two new and three established technologies.
Sorg N; Poppe C; Bunos M; Wingenfeld E; Hümmer C; Krämer A; Stock B; Seifried E; Bonig H
Transfusion; 2015 Jun; 55(6):1275-82. PubMed ID: 25647556
[TBL] [Abstract][Full Text] [Related]
40. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
